Drug Type Small molecule drug |
Synonyms succinate prodrug (Imbira Pharmaceuticals) |
Target |
Mechanism SDH2 modulators(Succinate dehydrogenase modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Imbria Pharmaceuticals, Inc.Startup |
Active Organization Imbria Pharmaceuticals, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metabolism, Inborn Errors | Preclinical | US | Imbria Pharmaceuticals, Inc.Startup | - |